4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-017107
CHIEF CLINICAL OFFICER acquired 938,646 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
MAIDA ANTHONY E III · CHIEF CLINICAL OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Conversion : show line 1 in the form | +938,646 | 1,137,314 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-31 | Conversion : show line 2 in the form Series A Convertible Preferred Stock | −938 | 0 | D |
| 2021-07-08 | Grant or award : show line 3 in the form Stock Options | +400,000 | 400,000 | D |
Loading xslF345X03/ownership.xml…